http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories
-
Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Translate Bio (TBIO) Achieves Manufacturing Milestone Related to Influenza mRNA Vaccine Program
-
Translate Bio Achieves Manufacturing Milestone Related to Influenza mRNA Vaccine Program
-
Translate Bio Achieves Manufacturing Milestone Related to Influenza mRNA Vaccine Program
-
Translate Bio to Participate in Upcoming Investor Conferences
-
Translate Bio Presents Preclinical Results in Primary Ciliary Dyskinesia (PCD) at American Thoracic Society (ATS) 2021 International Conference
-
Translate Bio Announces First Quarter 2021 Financial Results and Provides Corporate Update
-
Translate Bio Announces First Quarter 2021 Financial Results and Provides Corporate Update
-
Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Translate Bio to Present at the 7th Annual Truist Securities Life Sciences Summit
-
Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Translate Bio (TBIO) announces Brendan Smith appointed as Chief Financial Officer
-
Translate Bio (TBIO) Reports Publication of Preclinical Results of COVID-19 mRNA Vaccine Candidate MRT5500 in npj Vaccines
-
Translate Bio Announces Key Leadership Additions and Promotions
-
Translate Bio Announces Publication of Preclinical Results of COVID-19 mRNA Vaccine Candidate MRT5500 in npj Vaccines
-
Translate Bio Announces Key Leadership Additions and Promotions
-
Translate Bio Announces Publication of Preclinical Results of COVID-19 mRNA Vaccine Candidate MRT5500 in npj Vaccines
-
Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Translate Bio (TBIO) Appoints Dr. Rand Sutherland as President
-
Translate Bio Appoints Dr. Rand Sutherland as President
-
Translate Bio Appoints Dr. Rand Sutherland as President
-
Translate Bio (TBIO) Announces Results from Second Interim Data Analysis from Ongoing Phase 1/2 Clinical Trial of MRT5005 in Patients with Cystic Fibrosis
-
Translate Bio Announces Results from Second Interim Data Analysis from Ongoing Phase 1/2 Clinical Trial of MRT5005 in Patients with Cystic Fibrosis (CF)
-
Translate Bio Announces Results from Second Interim Data Analysis from Ongoing Phase 1/2 Clinical Trial of MRT5005 in Patients with Cystic Fibrosis (CF)
-
Translate Bio to Participate in Upcoming Investor Conferences
-
Translate Bio (TBIO) Resumes Enrollment and Dosing in Phase 1/2 Clinical Trial of MRT5005 in Cystic Fibrosis
-
Translate Bio Resumes Enrollment and Dosing in Phase 1/2 Clinical Trial of MRT5005 in Cystic Fibrosis
-
Translate Bio Resumes Enrollment and Dosing in Phase 1/2 Clinical Trial of MRT5005 in Cystic Fibrosis
-
Translate Bio to Participate in Upcoming Investor Conferences
-
Translate Bio Announces Second Quarter 2020 Financial Results and Reviews Recent Progress
-
Translate Bio Announces Second Quarter 2020 Financial Results and Reviews Recent Progress
-
Translate Bio Announces Closing of Expanded Collaboration and Licensing Agreement with Sanofi Pasteur to Develop mRNA Vaccines for All Infectious Diseases
-
Translate Bio Announces Closing of Expanded Collaboration and Licensing Agreement with Sanofi Pasteur to Develop mRNA Vaccines for All Infectious Diseases
-
Sanofi (SNY), Translate Bio (TBIO) Report Collaboration Expansion to Develop mRNA Vaccines Across All Infectious Disease Areas
-
Sanofi and Translate Bio Expand Collaboration to Develop mRNA Vaccines Across All Infectious Disease Areas
-
Sanofi and Translate Bio expand collaboration to develop mRNA vaccines across all infectious disease areas
-
Sanofi and Translate Bio Expand Collaboration to Develop mRNA Vaccines Across All Infectious Disease Areas
-
Translate Bio to Present at Jefferies Virtual Healthcare Conference
-
Translate Bio to Present at Jefferies Virtual Healthcare Conference
-
Translate Bio to Present at the Bank of America Securities Virtual 2020 Healthcare Conference
-
Translate Bio to Present at the Bank of America Securities Virtual 2020 Healthcare Conference
-
Translate Bio Announces First Quarter 2020 Financial Results and Provides Corporate Update
-
Translate Bio Announces First Quarter 2020 Financial Results and Provides Corporate Update
-
Translate Bio (TBIO), Sanofi Pasteur (SNY) Announce Collaboration to Develop a Novel mRNA Vaccine Candidate Against COVID-19
-
Sanofi Pasteur and Translate Bio to Collaborate to Develop a Novel mRNA Vaccine Candidate Against COVID-19
-
Sanofi and Translate Bio collaborate to develop novel mRNA vaccine candidate against COVID-19
-
Sanofi Pasteur and Translate Bio to Collaborate to Develop a Novel mRNA Vaccine Candidate Against COVID-19
